These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Interstitial pneumopathy and low-dosage amiodarone. Pozzi E; Sada E; Luisetti M; De Rose V; Scelsi M Eur J Respir Dis; 1984 Nov; 65(8):620-2. PubMed ID: 6519218 [TBL] [Abstract][Full Text] [Related]
25. [Hyperpigmentation caused by amiodaron]. Lakatos A; Török L; Szücs M; Oze B Orv Hetil; 1985 Jun; 126(22):1343-5. PubMed ID: 3159995 [No Abstract] [Full Text] [Related]
26. [Amiodarone and the thyroid gland: apropos of 2 cases of hypothyroidism]. Pucciarelli G; Caso P; Jacono A Clin Ter; 1978 Jan; 84(1):81-4. PubMed ID: 630815 [No Abstract] [Full Text] [Related]
27. Amiodarone. The dilemma of hyperthyroxinaemia and the treatment of thyrotoxicosis. Donaghue KC; Clarke P; Hooper MJ Med J Aust; 1985 May; 142(11):594-6. PubMed ID: 3923304 [TBL] [Abstract][Full Text] [Related]
28. [Spectrometric and ultrastructural study of pneumopathy induced by amiodarone]. Breton JL; Depierre A; Garnier G Ann Med Interne (Paris); 1985; 136(1):76-7. PubMed ID: 4003996 [No Abstract] [Full Text] [Related]
29. [Lung changes in amiodarone therapy]. Prayer L; Hübsch P; Frank H Pneumologie; 1989 Nov; 43(11):673-5. PubMed ID: 2608645 [TBL] [Abstract][Full Text] [Related]
30. Amiodarone. Med Lett Drugs Ther; 1986 May; 28(713):49-50. PubMed ID: 3702807 [No Abstract] [Full Text] [Related]
31. [Interstitial pneumopathy and amiodarone]. Tatti V; Ramelli G Schweiz Med Wochenschr; 1986 Mar; 116(12):377-82. PubMed ID: 2421401 [TBL] [Abstract][Full Text] [Related]
32. [Severe pneumopathy and amiodarone]. Chebat J; Caubarrère I Therapie; 1983; 38(1):111-2. PubMed ID: 6867993 [No Abstract] [Full Text] [Related]
33. [Lung, mirror of iatrogenic diseases. Example of amiodarone]. Michel FB; Godard P; Aubas P; Vic P Bull Acad Natl Med; 1986 Jan; 170(1):157-63. PubMed ID: 3527348 [No Abstract] [Full Text] [Related]
34. [Amiodarone: a new cause of hypersensitivity pneumopathy?]. Arlet P; Carré P; Bismuth JM; Larregain-Fournier D; Le Tallec Y Rev Pneumol Clin; 1984; 40(3):205-7. PubMed ID: 6463506 [TBL] [Abstract][Full Text] [Related]
35. Possible recurrence of amiodarone pulmonary toxicity following corticosteroid therapy. Joelson J; Kluger J; Cole S; Conway M Chest; 1984 Feb; 85(2):284-6. PubMed ID: 6692713 [TBL] [Abstract][Full Text] [Related]
36. Amiodarone keratopathy. Klingele TG; Alves LE; Rose EP Ann Ophthalmol; 1984 Dec; 16(12):1172-6. PubMed ID: 6532293 [TBL] [Abstract][Full Text] [Related]
37. [Usefulness of the reverse T3 (rT3) determination in patients under chronic treatment with amiodarone]. de los Angeles Valenzuela M; Bianchi C; Meruane J; Pineda G Rev Med Chil; 1984 Mar; 112(3):228-32. PubMed ID: 6473963 [No Abstract] [Full Text] [Related]
38. [Changes in thyroid function during anti-arrhythmia therapy with amiodaron]. Pickardt CR Dtsch Med Wochenschr; 1983 Dec; 108(48):1856-7. PubMed ID: 6641539 [No Abstract] [Full Text] [Related]
39. [Severe arrhythmia induced by amiodarone: review of 11 cases]. Sun JP Zhonghua Xin Xue Guan Bing Za Zhi; 1985 Mar; 13(1):21-3. PubMed ID: 4006699 [No Abstract] [Full Text] [Related]
40. Amiodarone keratopathy. Fraunfelder FT; Meyer SM Trans Ophthalmol Soc N Z; 1984; 36():33-4. PubMed ID: 6591610 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]